Peptide Cosmetic API
完整報告名稱與涵蓋範圍
Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035
報告摘要
Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035
Market Overview
Global peptide cosmetic API market generated USD 921.3 million in revenue in 2024 and expected to achieve USD 2,968.4 million by 2035 at a CAGR of 11.2%.
Global peptide cosmetic API market is being significantly driven by the rising demand for natural and organic cosmetic products, as consumers increasingly seek safer and more skin-friendly alternatives. Technological advancements in peptide synthesis have further propelled market growth, enabling the development of more stable and effective formulations. Additionally, the growing trend toward personalized skincare has heightened the appeal of peptides, which can be tailored to target specific skin concerns. Ongoing research highlighting the dermatological benefits of peptides continues to support their widespread adoption in cosmetic applications.
However, the market faces several restraints, including the high cost of peptide synthesis and formulation, challenges in stability and effective delivery, and stringent regulatory requirements that often lead to approval delays. Furthermore, the presence of alternative active ingredients adds to competitive pressures.
Despite these challenges, the global market presents strong opportunities, particularly in areas like bioengineered peptides for clean beauty, AI-powered skincare personalization, men's grooming with anti-aging solutions, multi-step skincare innovations, and innovations in peptide research.
Market Segmentations
By application category, the Global peptide cosmetic API market is divided into anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing.
Based on the source type, the global market is included plant-derived peptides, animal-derived peptides, bioengineered peptides, chemically synthesized.
Skincare, haircare, injectable cosmetics, and others are the part of end-use type of the global peptide cosmetic API market.
Regional Insights
North America dominates global peptide cosmetic API market owing to strong consumer awareness, a solid base of established cosmetic companies, and rising demand for advanced anti-aging and functional skincare products. The presence of leading R&D centers and an inclination toward premium, scientifically backed formulas further supports market leadership.
Europe is close behind, driven by the clean beauty movement, stringent safety regulations, and a well-developed anti-aging segment in markets like France, the UK, and Germany.
Asia-Pacific exhibits the fastest expansion, fueled by increasing skincare awareness, influence from K-beauty and J-beauty trends, and accelerating urbanization in key nations like China, Japan, and South Korea. Consumers here are drawn to multifunctional, innovative cosmetics.
Latin America, especially Brazil, is steadily rising due to growing interest in natural and age-defying formulations.
The Middle East & Africa region is showing gradual development, primarily supported by urban areas and a rise in disposable income levels.
Major Players
Major players of global peptide cosmetic API research report are Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.
授權報價
| Single User Price | $4,950 USD |
| Multi User Licence (up to 10 users) | $5,950 USD |
| Enterprisewide Price (Global Site License) | $7,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY .......................................... 21
2 MARKET INTRODUCTION ...................................... 23
2.1 DEFINITION .................... 23
2.2 SCOPE OF THE STUDY ....................................................................... 23
2.3 RESEARCH OBJECTIVE ..................................................................... 23
2.4 MARKET STRUCTURE ....................................................................... 24
3 RESEARCH METHODOLOGY ................................. 26
3.1 OVERVIEW ...................... 26
3.2 DATA FLOW .................... 28
3.2.1 DATA MINING PROCESS ................................................................ 28
3.3 PURCHASED DATABASE: .................................................................. 29
3.4 SECONDARY SOURCES: ..................................................................... 30
3.4.1 SECONDARY RESEARCH DATA FLOW: ................................................ 31
3.5 PRIMARY RESEARCH: ........................................................................ 32
3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................ 33
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED .................. 34
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ....................................... 34
3.6 APPROACHES FOR MARKET END USER ESTIMATION: ........ 35
3.6.1 REVENUE ANALYSIS APPROACH ..................................................... 35
3.6.2 DATA FORECASTING ...................................................................... 36
3.6.3 DATA FORECASTING TECHNIQUE ..................................................... 36
3.7 DATA MODELING .......... 37
3.7.1 MICROECONOMIC FACTOR ANALYSIS: ................................................ 37
3.7.2 DATA MODELING: ........................................................................ 38
3.8 TEAMS AND ANALYST CONTRIBUTION .................................... 39
4 MARKET DYNAMICS ............................................... 41
4.1 INTRODUCTION ............. 41
4.2 DRIVERS ........................... 42
4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS ............. 42
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS ................... 42
4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS ........... 43
4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY ........... 43
4.3 RESTRAINTS .................. 43
4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION ....................... 43
4.3.2 STABILITY AND DELIVERY CHALLENGES .............................................. 44
4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS ........................... 44
4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS........................ 44
4.4 OPPORTUNITY ............... 45
4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY ................................... 45
4.4.2 AI-DRIVEN PERSONALIZED SKINCARE ............................................... 45
4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS................................. 45
4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS ................................. 46
4.4.5 INNOVATIONS IN PEPTIDE RESEARCH ............................................... 46
4.5 IMPACT ANALYSIS OF COVID – 19 ................................................ 47
4.5.1 IMPACT 0N OVERALL HEALTHCARE. .............................................. 47
4.5.2 ECONOMIC IMPACT. ................................................................ 47
4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET. ... 48
4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET..... 48
4.5.5 PRICE VARIATION OF KEY RAW MATERIALS. ............................ 48
4.5.6 PRODUCTION SHUTDOWN. ...................................................... 49
4.5.7 CASH FLOW CONSTRAINTS. .................................................... 49
4.5.8 IMPACT ON IMPORT/EXPORT. ................................................. 49
4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET. ...................................................................... 50
4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN. ........................... 50
4.5.11 CONSUMER SENTIMENTS. ....................................................... 50
4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET. ............ 51
5 MARKET FACTOR ANALYSIS ................................. 52
5.1 SUPPLY CHAIN ANALYSIS .............................................................. 52
5.1.1 RAW MATERIAL PROCUREMENT .............................................. 53
5.1.2 MANUFACTURING & SYNTHESIS .............................................. 53
5.1.3 PACKAGING AND STORAGE ..................................................... 54
5.1.4 DISTRIBUTION & LOGISTICS ..................................................... 54
5.1.5 END-USERS & CONSUMER DELIVERY ........................................ 54
5.2 PORTER’S FIVE FORCES MODEL .................................................... 55
5.2.1 BARGAINING POWER OF SUPPLIERS .................................................. 55
5.2.2 BARGAINING POWER OF BUYERS ..................................................... 56
5.2.3 THREAT OF NEW ENTRANTS ............................................................ 56
5.2.4 THREAT OF SUBSTITUTES ............................................................... 56
5.2.5 INTENSITY OF RIVALRY ................................................................... 57
6 PEPTIDE COSMETIC API MARKET, BY APPLICATION .............................................................. 59
6.1 INTRODUCTION ............. 59
6.2 ANTI-AGING & WRINKLE REDUCTION ........................................ 59
6.3 SKIN REPAIR & REGENERATION ................................................... 60
6.4 MOISTURIZING & HYDRATION ....................................................... 60
6.5 WHITENING & BRIGHTENING ......................................................... 60
6.6 HAIR CARE ...................... 61
6.7 ANTI-INFLAMMATORY & SOOTHING .......................................... 61
7 PEPTIDE COSMETIC API MARKET, BY SOURCE . 62
7.1 INTRODUCTION ............. 62
7.2 PLANT-DERIVED PEPTIDES ............................................................ 62
7.3 ANIMAL-DERIVED PEPTIDES ......................................................... 62
7.4 BIOENGINEERED PEPTIDES ............................................................. 63
7.5 CHEMICALLY SYNTHESIZED .......................................................... 63
8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY.................................................... 64
8.1 INTRODUCTION ............. 64
8.2 SKINCARE ....................... 64
8.3 HAIRCARE ....................... 64
8.4 INJECTABLE COSMETICS ................................................................. 65
8.5 OTHERS ............................ 65
9 PEPTIDE COSMETIC API MARKET, BY REGION .. 66
9.1 OVERVIEW ...................... 66
9.2 NORTH AMERICA ......... 67
9.2.1 US.................... 68
9.2.2 CANADA ............ 69
9.3 EUROPE ............................ 70
9.3.1 GERMANY .......... 71
9.3.2 UK ................... 73
9.3.3 FRANCE ........... 74
9.3.4 RUSSIA ............ 75
9.3.5 ITALY ............... 76
9.3.6 SPAIN .............. 77
9.3.7 REST OF EUROPE ..................................................................... 78
9.4 APAC ................................. 79
9.4.1 CHINA ............... 80
9.4.2 INDIA ............... 81
9.4.3 JAPAN ............. 82
9.4.4 SOUTH KOREA .. 83
9.4.5 MALAYSIA ....... 84
9.4.6 THAILAND ........ 85
9.4.7 INDONESIA ....... 86
9.4.8 REST OF APAC ........................................................................ 87
9.5 SOUTH AMERICA ......... 88
9.5.1 BRAZIL ............... 89
9.5.2 MEXICO ........... 91
9.5.3 ARGENTINA ..... 92
9.5.4 REST OF SOUTH AMERICA ....................................................... 93
9.6 MEA ................................... 94
9.6.1 GCC COUNTRIES .. 95
9.6.2 SOUTH AFRICA ..... 96
9.6.3 REST OF MEA ..... 97
10 COMPETITIVE LANDSCAPE ................................... 99
10.1 INTRODUCTION ............. 99
10.2 MARKET SHARE ANALYSIS, 2023 ................................................ 99
10.3 COMPETITOR DASHBOARD.............................................................. 101
11 COMPANY PROFILES ............................................. 102
11.1 DSM-FIRMENICH .......... 102
11.1.1 COMPANY OVERVIEW .............................................................. 102
11.1.2 FINANCIAL OVERVIEW.............................................................. 103
11.1.3 TYPES OFFERED ...................................................................... 103
11.1.4 PATENT DETAILS ... 104
11.1.5 PRODUCTION CAPACITY ................................................................ 104
11.1.6 SALES VOLUME ... 104
11.1.7 PRICING ANALYSIS ....................................................................... 105
11.1.8 SWOT ANALYSIS ..................................................................... 105
11.1.9 KEY STRATEGY ..... 106
11.2 BACHEM .......................... 107
11.2.1 COMPANY OVERVIEW .............................................................. 107
11.2.2 FINANCIAL OVERVIEW.............................................................. 108
11.2.3 TYPES OFFERED ...................................................................... 108
11.2.4 PATENT DETAILS ... 109
11.2.5 PRODUCTION CAPACITY ................................................................ 109
11.2.6 SALES VOLUME ... 109
11.2.7 PRICING ANALYSIS ....................................................................... 109
11.2.8 SWOT ANALYSIS ..................................................................... 110
11.2.9 KEY STRATEGY ..... 110
11.3 LIPOTRUE SCIENCE ..... 111
11.3.1 COMPANY OVERVIEW .............................................................. 111
11.3.2 TYPES OFFERED ...................................................................... 111
11.3.3 PATENT DETAILS ... 111
11.3.4 PRODUCTION CAPACITY ................................................................ 112
11.3.5 SALES VOLUME ... 112
11.3.6 PRICING ANALYSIS ....................................................................... 112
11.3.7 SWOT ANALYSIS ..................................................................... 113
11.3.8 KEY STRATEGY ..... 113
11.4 CRODA ............................... 114
11.4.1 COMPANY OVERVIEW .............................................................. 114
11.4.2 FINANCIAL OVERVIEW.............................................................. 115
11.4.3 TYPES OFFERED ...................................................................... 115
11.4.4 PATENT DETAILS ... 116
11.4.5 PRODUCTION CAPACITY ................................................................ 116
11.4.6 SALES VOLUME ... 116
11.4.7 PRICING ANALYSIS ....................................................................... 116
11.4.8 SWOT ANALYSIS ..................................................................... 117
11.4.9 KEY STRATEGY ..... 117
11.5 CAREGEN ......................... 118
11.5.1 COMPANY OVERVIEW .............................................................. 118
11.5.2 TYPES OFFERED ...................................................................... 118
11.5.3 PATENT DETAILS ... 118
11.5.4 PRODUCTION CAPACITY ................................................................ 119
11.5.5 SALES VOLUME ... 119
11.5.6 PRICING ANALYSIS ....................................................................... 119
11.5.7 SWOT ANALYSIS ..................................................................... 120
11.5.8 KEY STRATEGY ..... 120
11.6 BASF SE ............................ 121
11.6.1 COMPANY OVERVIEW .............................................................. 121
11.6.2 FINANCIAL OVERVIEW.............................................................. 121
11.6.3 TYPES OFFERED ...................................................................... 122
11.6.4 PATENT DETAILS ... 122
11.6.5 PRODUCTION CAPACITY ................................................................ 122
11.6.6 SALES VOLUME ... 123
11.6.7 PRICING ANALYSIS ....................................................................... 123
11.6.8 SWOT ANALYSIS ..................................................................... 123
11.6.9 KEY STRATEGY ..... 124
11.7 EVONIK INDUSTRIES AG .................................................................. 125
11.7.1 COMPANY OVERVIEW ............................................................. 125
11.7.2 FINANCIAL OVERVIEW.............................................................. 126
11.7.3 TYPES OFFERED ...................................................................... 126
11.7.4 PATENT DETAILS ... 127
11.7.5 PRODUCTION CAPACITY ................................................................ 127
11.7.6 SALES VOLUME ... 127
11.7.7 PRICING ANALYSIS ....................................................................... 127
11.7.8 SWOT ANALYSIS ..................................................................... 128
11.7.9 KEY STRATEGY ..... 128
11.8 GIVAUDAN ACTIVE BEAUTY .......................................................... 129
11.8.1 COMPANY OVERVIEW ............................................................. 129
11.8.2 FINANCIAL OVERVIEW.............................................................. 129
11.8.3 TYPES OFFERED ...................................................................... 130
11.8.4 PATENT DETAILS ... 130
11.8.5 PRODUCTION CAPACITY ................................................................ 130
11.8.6 SALES VOLUME ... 130
11.8.7 PRICING ANALYSIS ....................................................................... 131
11.8.8 SWOT ANALYSIS ..................................................................... 131
11.8.9 KEY STRATEGY ..... 132
11.9 ASHLAND GLOBAL HOLDINGS ........................................................ 133
11.9.1 COMPANY OVERVIEW .............................................................. 133
11.9.2 FINANCIAL OVERVIEW.............................................................. 133
11.9.3 TYPES OFFERED ...................................................................... 134
11.9.4 PATENT DETAILS ... 134
11.9.5 PRODUCTION CAPACITY ................................................................ 134
11.9.6 SALES VOLUME ... 134
11.9.7 PRICING ANALYSIS ....................................................................... 135
11.9.8 SWOT ANALYSIS ..................................................................... 135
11.9.9 KEY STRATEGY ..... 135
11.10 SYMRISE AG ................... 136
11.10.1 COMPANY OVERVIEW .............................................................. 136
11.10.2 FINANCIAL OVERVIEW.............................................................. 136
11.10.3 TYPES OFFERED ...................................................................... 137
11.10.4 PATENT DETAILS ... 137
11.10.5 PRODUCTION CAPACITY ................................................................ 137
11.10.6 SALES VOLUME ... 137
11.10.7 PRICING ANALYSIS ....................................................................... 137
11.10.8 SWOT ANALYSIS ..................................................................... 138
11.10.9 KEY STRATEGY ..... 138
11.11 PROVITAL GROUP ........ 139
11.11.1 COMPANY OVERVIEW .............................................................. 139
11.11.2 TYPES OFFERED ...................................................................... 139
11.11.3 PATENT DETAILS ... 139
11.11.4 PRODUCTION CAPACITY ................................................................ 140
11.11.5 SALES VOLUME ... 140
11.11.6 PRICING ANALYSIS ....................................................................... 140
11.11.7 SWOT ANALYSIS ..................................................................... 141
11.11.8 KEY STRATEGY ..... 141
11.12 SPEC-CHEM INDUSTRY INC ............................................................ 142
11.12.1 COMPANY OVERVIEW .............................................................. 142
11.12.2 TYPES OFFERED ...................................................................... 142
11.12.3 PATENT DETAILS ... 142
11.12.4 PRODUCTION CAPACITY ................................................................ 143
11.12.5 SALES VOLUME ... 143
11.12.6 PRICING ANALYSIS ....................................................................... 143
11.12.7 SWOT ANALYSIS ..................................................................... 144
11.12.8 KEY STRATEGY ..... 144
11.13 AMBIOPHARM ............... 145
11.13.1 COMPANY OVERVIEW .............................................................. 145
11.13.2 TYPES OFFERED ...................................................................... 145
11.13.3 PATENT DETAILS ... 145
11.13.4 PRODUCTION CAPACITY ................................................................ 146
11.13.5 SALES VOLUME ... 146
11.13.6 PRICING ANALYSIS ....................................................................... 146
11.13.7 SWOT ANALYSIS ..................................................................... 147
11.13.8 KEY STRATEGY ..... 147
11.14 LIPOTEC ........................... 148
11.14.1 COMPANY OVERVIEW ............................................................. 148
11.14.2 TYPES OFFERED ...................................................................... 148
11.14.3 PATENT DETAILS ... 148
11.14.4 PRODUCTION CAPACITY ................................................................ 149
11.14.5 SALES VOLUME ... 149
11.14.6 PRICING ANALYSIS ....................................................................... 149
11.14.7 SWOT ANALYSIS ..................................................................... 150
11.14.8 KEY STRATEGY ..... 150
11.15 USV PRIVATE LIMITED ..................................................................... 151
11.15.1 COMPANY OVERVIEW ............................................................. 151
11.15.2 TYPES OFFERED ...................................................................... 151
11.15.3 PATENT DETAILS ... 151
11.15.4 PRODUCTION CAPACITY ................................................................ 152
11.15.5 SALES VOLUME ... 152
11.15.6 PRICING ANALYSIS ....................................................................... 152
11.15.7 SWOT ANALYSIS ..................................................................... 153
11.15.8 KEY STRATEGY ..... 153
11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR) ........................................................... 154
11.16.1 COMPANY OVERVIEW .............................................................. 154
11.16.2 TYPES OFFERED ...................................................................... 154
11.16.3 PATENT DETAILS ... 154
11.16.4 PRODUCTION CAPACITY ................................................................ 155
11.16.5 SALES VOLUME ... 155
11.16.6 PRICING ANALYSIS ....................................................................... 155
11.16.7 SWOT ANALYSIS ..................................................................... 156
11.16.8 KEY STRATEGY ..... 156
11.17 ACTIVE PEPTIDE COMPANY ........................................................... 157
11.17.1 COMPANY OVERVIEW .............................................................. 157
11.17.2 TYPES OFFERED ...................................................................... 157
11.17.3 PATENT DETAILS ... 158
11.17.4 PRODUCTION CAPACITY ................................................................ 158
11.17.5 SALES VOLUME ... 158
11.17.6 PRICING ANALYSIS ....................................................................... 158
11.17.7 SWOT ANALYSIS ..................................................................... 159
11.17.8 KEY STRATEGY ..... 159
11.18 SEIWA KASEI CO., LTD ....................................................................... 160
11.18.1 COMPANY OVERVIEW ............................................................. 160
11.18.2 TYPES OFFERED ...................................................................... 160
11.18.3 PATENT DETAILS ... 160
11.18.4 PRODUCTION CAPACITY ................................................................ 161
11.18.5 SALES VOLUME ... 161
11.18.6 PRICING ANALYSIS ....................................................................... 161
11.18.7 SWOT ANALYSIS ..................................................................... 162
11.18.8 KEY STRATEGY ..... 162
11.19 RS SYNTHESIS ............... 163
11.19.1 COMPANY OVERVIEW .............................................................. 163
11.19.2 TYPES OFFERED ...................................................................... 163
11.19.3 PATENT DETAILS ... 163
11.19.4 PRODUCTION CAPACITY ................................................................ 164
11.19.5 SALES VOLUME ... 164
11.19.6 PRICING ANALYSIS ....................................................................... 164
11.19.7 SWOT ANALYSIS ..................................................................... 165
11.19.8 KEY STRATEGY ..... 165
11.20 BCN PEPTIDES ............... 166
11.20.1 COMPANY OVERVIEW .............................................................. 166
11.20.2 TYPES OFFERED ...................................................................... 166
11.20.3 PATENT DETAILS ... 166
11.20.4 PRODUCTION CAPACITY ................................................................ 167
11.20.5 SALES VOLUME ... 167
11.20.6 PRICING ANALYSIS ....................................................................... 167
11.20.7 SWOT ANALYSIS ..................................................................... 168
11.20.8 KEY STRATEGY ............................................................................ 168
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 59
TABLE 2 PEPTIDE COSMETIC API MARKET, SOURCE, 2019-2035 (USD MILLION) 62
TABLE 3 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 64
TABLE 4 PEPTIDE COSMETIC API MARKET, BY REGION, 2019-2035 (USD MILLION) 66
TABLE 5 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY COUNTRY, 2019-2035 (USD MILLION) 67
TABLE 6 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY APPLICATION, 2019-2035 (USD MILLION) 67
TABLE 7 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY SOURCE, 2019-2035 (USD MILLION) 67
TABLE 8 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 68
TABLE 9 US: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 68
TABLE 10 US: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 68
TABLE 11 US: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 69
TABLE 12 CANADA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 69
TABLE 13 CANADA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 69
TABLE 14 CANADA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 70
TABLE 15 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY COUNTRY, 2019-2035 (USD MILLION) 70
TABLE 16 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY APPLICATION, 2019-2035 (USD MILLION) 70
TABLE 17 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY SOURCE, 2019-2035 (USD MILLION) 71
TABLE 18 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 71
TABLE 19 GERMANY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 71
TABLE 20 GERMANY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 72
TABLE 21 GERMANY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 72
TABLE 22 UK: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 73
TABLE 23 UK: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 73
TABLE 24 UK: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 73
TABLE 25 FRANCE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 74
TABLE 26 FRANCE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 74
TABLE 27 FRANCE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 74
TABLE 28 RUSSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 75
TABLE 29 RUSSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 75
TABLE 30 RUSSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 75
TABLE 31 ITALY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 76
TABLE 32 ITALY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 76
TABLE 33 ITALY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 76
TABLE 34 SPAIN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 77
TABLE 35 SPAIN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 77
TABLE 36 SPAIN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 77
TABLE 37 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 78
TABLE 38 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 78
TABLE 39 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 78
TABLE 40 PEPTIDE COSMETIC API MARKET, FOR APAC , BY COUNTRY, 2019-2035 (USD MILLION) 79
TABLE 41 PEPTIDE COSMETIC API MARKET, FOR APAC , BY APPLICATION, 2019-2035 (USD MILLION) 79
TABLE 42 PEPTIDE COSMETIC API MARKET, FOR APAC , BY SOURCE, 2019-2035 (USD MILLION) 79
TABLE 43 PEPTIDE COSMETIC API MARKET, FOR APAC , BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 80
TABLE 44 CHINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80
TABLE 45 CHINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 80
TABLE 46 CHINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 81
TABLE 47 INDIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 81
TABLE 48 INDIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 81
TABLE 49 INDIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 82
TABLE 50 JAPAN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 82
TABLE 51 JAPAN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 82
TABLE 52 JAPAN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 83
TABLE 53 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 83
TABLE 54 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 83
TABLE 55 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 84
TABLE 56 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84
TABLE 57 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 84
TABLE 58 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 85
TABLE 59 THAILAND: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 85
TABLE 60 THAILAND: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 85
TABLE 61 THAILAND: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 86
TABLE 62 INDONESIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 86
TABLE 63 INDONESIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 86
TABLE 64 INDONESIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 87
TABLE 65 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 87
TABLE 66 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 87
TABLE 67 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 88
TABLE 68 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY COUNTRY, 2019-2035 (USD MILLION) 88
TABLE 69 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY APPLICATION, 2019-2035 (USD MILLION) 88
TABLE 70 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY SOURCE, 2019-2035 (USD MILLION) 89
TABLE 71 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 89
TABLE 72 BRAZIL: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 89
TABLE 73 BRAZIL: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 90
TABLE 74 BRAZIL: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 90
TABLE 75 MEXICO: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 91
TABLE 76 MEXICO: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 91
TABLE 77 MEXICO: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 91
TABLE 78 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 92
TABLE 79 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 92
TABLE 80 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 92
TABLE 81 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 93
TABLE 82 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 93
TABLE 83 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 93
TABLE 84 PEPTIDE COSMETIC API MARKET, FOR MEA, BY COUNTRY, 2019-2035 (USD MILLION) 94
TABLE 85 PEPTIDE COSMETIC API MARKET, FOR MEA, BY APPLICATION, 2019-2035 (USD MILLION) 94
TABLE 86 PEPTIDE COSMETIC API MARKET, FOR MEA, BY SOURCE, 2019-2035 (USD MILLION) 94
TABLE 87 PEPTIDE COSMETIC API MARKET, FOR MEA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 95
TABLE 88 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 95
TABLE 89 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 95
TABLE 90 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 96
TABLE 91 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 96
TABLE 92 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 96
TABLE 93 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 97
TABLE 94 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 97
TABLE 95 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 97
TABLE 96 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 98
TABLE 97 DSM-FIRMENICH: PRODUCT OFFERED 103
TABLE 98 BACHEM: PRODUCT OFFERED 108
TABLE 99 LIPOTRUE SCIENCE: PRODUCT OFFERED 111
TABLE 100 CRODA: PRODUCT OFFERED 115
TABLE 101 CAREGEN: PRODUCT OFFERED 118
TABLE 102 BASF SE: PRODUCT OFFERED 122
TABLE 103 EVONIK INDUSTRIES AG: PRODUCT OFFERED 126
TABLE 104 GIVAUDAN ACTIVE BEAUTY: PRODUCT OFFERED 130
TABLE 105 ASHLAND GLOBAL HOLDINGS: PRODUCT OFFERED 134
TABLE 106 SYMRISE AG: PRODUCT OFFERED 137
TABLE 107 PROVITAL GROUP: PRODUCT OFFERED 139
TABLE 108 SPEC-CHEM INDUSTRY INC: PRODUCT OFFERED 142
TABLE 109 AMBIOPHARM: PRODUCT OFFERED 145
TABLE 110 LIPOTEC: PRODUCT OFFERED 148
TABLE 111 USV PRIVATE LIMITED: PRODUCT OFFERED 151
TABLE 112 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): PRODUCT OFFERED 154
TABLE 113 ACTIVE PEPTIDE COMPANY: PRODUCT OFFERED 157
TABLE 114 SEIWA KASEI CO., LTD: PRODUCT OFFERED 160
TABLE 115 RS SYNTHESIS: PRODUCT OFFERED 163
TABLE 116 BCN PEPTIDES: PRODUCT OFFERED 166
LIST OF FIGURES
FIGURE 1 PEPTIDE COSMETIC API MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035) 41
FIGURE 3 SUPPLY CHAIN ANALYSIS: PEPTIDE COSMETIC API MARKET 52
FIGURE 5 PORTER’S FIVE FORCES MODEL: PEPTIDE COSMETIC API MARKET 55
FIGURE 6 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2023 (% SHARE) 61
FIGURE 7 PEPTIDE COSMETIC API MARKET, BY SOURCE, 2023 (% SHARE) 63
FIGURE 8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2023 (% SHARE) 65
FIGURE 9 GLOBAL PEPTIDE COSMETIC API MARKET PLAYERS: COMPETITIVE ANALSIS, 2023 99
FIGURE 10 INDUSTRY CONCENTRATION, 2024 100
FIGURE 11 COMPETITOR DASHBOARD: GLOBAL MILITARY DRIVER VISION ENHANCER 101
FIGURE 12 DSM-FIRMENICH: FINANCIAL OVERVIEW SNAPSHOT 103
FIGURE 13 DSM-FIRMENICH: SWOT ANALYSIS 105
FIGURE 14 BACHEM: FINANCIAL OVERVIEW SNAPSHOT 108
FIGURE 15 BACHEM: SWOT ANALYSIS 110
FIGURE 16 LIPOTRUE SCIENCE: SWOT ANALYSIS 113
FIGURE 17 CRODA: FINANCIAL OVERVIEW SNAPSHOT 115
FIGURE 18 CRODA: SWOT ANALYSIS 117
FIGURE 19 CAREGEN: SWOT ANALYSIS 120
FIGURE 20 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 21 BASF SE: SWOT ANALYSIS 123
FIGURE 22 EVONIK: FINANCIAL OVERVIEW SNAPSHOT 126
FIGURE 23 EVONIK INDUSTRIES AG: SWOT ANALYSIS 128
FIGURE 24 GIVAUDAN ACTIVE BEAUTY: FINANCIAL OVERVIEW SNAPSHOT 129
FIGURE 25 GIVAUDAN ACTIVE BEAUTY: SWOT ANALYSIS 131
FIGURE 26 ASHLAND GLOBAL HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT 133
FIGURE 27 ASHLAND GLOBAL HOLDINGS: SWOT ANALYSIS 135
FIGURE 28 SYMRISE AG: FINANCIAL OVERVIEW SNAPSHOT 136
FIGURE 29 SYMRISE AG: SWOT ANALYSIS 138
FIGURE 30 PROVITAL GROUP: SWOT ANALYSIS 141
FIGURE 31 SPEC-CHEM INDUSTRY INC: SWOT ANALYSIS 144
FIGURE 32 AMBIOPHARM: SWOT ANALYSIS 147
FIGURE 33 LIPOTEC: SWOT ANALYSIS 150
FIGURE 34 USV PRIVATE LIMITED: SWOT ANALYSIS 153
FIGURE 35 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): SWOT ANALYSIS 156
FIGURE 36 ACTIVE PEPTIDE COMPANY: SWOT ANALYSIS 159
FIGURE 37 SEIWA KASEI CO., LTD: SWOT ANALYSIS 162
FIGURE 38 RS SYNTHESIS: SWOT ANALYSIS 165
FIGURE 39 BCN PEPTIDES: SWOT ANALYSIS 168
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們